Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04897867 · ClinicalTrials.gov registry record · Phase 4
CoolSculpting® Elite for Non-Invasive Fat Reduction
A Phase 4 study of Non-invasive Fat Reduction, sponsored by Allergan.
- Completed
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
- 8
- Study locations
NCT04897867 is a Phase 4 study of Non-invasive Fat Reduction that has completed, run by Allergan. The registered enrollment target is 110 participants. The trial reports 8 study locations across 3 states.
The verdict
NCT04897867, a Phase 4 study of Non-invasive Fat Reduction, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study aims to generate data that conveys participant's experiences such as their satisfaction with treatment delivered by the redesigned CoolSculpting® Elite system for non-invasive fat reduction in the midsection area (abdomen and flanks) in addition to optional body areas of upper arms, inner thighs, outer thighs and/or submental area. By doing this, the study will provide insights for doctors to better inform participants about the expected outcomes when one or more body areas are considered for treatment.
Conditions Studied
Interventions
- DEVICE CoolSculpting® Elite System with CoolSculpting® Elite applicators
Study Locations (8)
Other
- Centre Laser International de la Peau /ID# 239117 - Paris
- Bodenseeklinik /Id# 239155 - Lindau
- Halley Medical Aesthetics /ID# 239124 - Singapore
- Akademikliniken /ID# 239120 - Stockholm
California
- Laser & Skin Surgery Medical group, Inc /ID# 239112 - Sacramento
- Cosmetic Laser Dermatology /ID# 239110 - San Diego
- Cosmetic Laser Dermatology /ID# 239111 - San Diego
New York
- Laser & Skin Surgery Center of New York /ID# 239113 - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2021-05-18 |
| Est. Completion | 2022-06-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04897867
The ClinicalTrials.gov registry entry for NCT04897867 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-invasive Fat Reduction appearing as the primary indexed condition, and to 1 intervention - of which CoolSculpting® Elite System with CoolSculpting® Elite applicators is the first listed.
NCT04897867 reports 8 study locations spanning 3 distinct geographic areas - top geographies include Other, California, New York.
Frequently Asked Questions
What is clinical trial NCT04897867 about?
NCT04897867 is a clinical study titled "CoolSculpting® Elite for Non-Invasive Fat Reduction". This study aims to generate data that conveys participant's experiences such as their satisfaction with treatment delivered by the redesigned CoolSculpting® Elite system for non-invasive fat reduction in the midsection area (abdomen and flanks) in addition to optional body areas of upper arms, inner...
What is the current status of trial NCT04897867?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2021-05-18. Estimated completion is 2022-06-15.
What conditions does trial NCT04897867 study?
This clinical trial studies the following conditions: Non-invasive Fat Reduction.
What interventions are being tested in trial NCT04897867?
The interventions under investigation include: CoolSculpting® Elite System with CoolSculpting® Elite applicators (DEVICE).
Who is sponsoring clinical trial NCT04897867?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04897867 being conducted?
This trial has 8 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.